Neuralink Seeks Second Human Participant for Brain-Computer Interface Trial

Following initial success and challenges with the first implant, Neuralink is expanding its clinical trial to further test its brain-computer interface technology.

Neuralink plans to implant two more participants with its brain-computer interface in the coming months.
The first participant, Noland Arbaugh, reports significant improvements in computer control using only his thoughts.
Arbaugh's implant faced initial technical issues, which the company has since addressed.
Neuralink's trials aim to help individuals with paralysis control digital devices through thought alone.
The company is recruiting volunteers with specific conditions, including quadriplegia and ALS, for its ongoing study.